Table 2. Mean values (M ± SD) of temperature, pulse and respiration in piperazine treated group (n = 20) and D_oraTG (n = 20).

Groups	Follow up period	Temperature (37°C ± 1°C)1 or (37.5°C–38.3°C)2	Pulse (Beat/minute) (38 ± 6)1 or (30–45)2	Respiration (/minute) (19 ± 6)1 or (10–20)2
PipTG	Day 0a	37.76 ± 0.28	43.29 ± 2.75	20.43 ± 1.72
	Day 7	37.77 ± 0.18	36.00 ± 3.11b	16.43 ± 1.13b
	Day 14	37.79 ± 0.23	34.57 ± 2.37b	13.43 ± 1.13b
	Day 21	37.84 ± 0.30	33.43 ± 1.51b	13.57 ± 1.62b
	Day 28	37.83 ± 0.20	32.14 ± 3.02b	12.14 ± 1.95b
DoraTG	Day 0a	37.6 ± 0.39	43.57 ± 2.37	19.57 ± 2.51
	Day 7	37.64 ± 0.23	38.00 ± 2.77c	14.86 ± 2.04c
	Day 14	37.76 ± 0.32	36.29 ± 1.98c	12.57 ± 1.51c
	Day 21	37.93 ± 0.25	34.71 ± 2.29c	12.86 ± 1.57c
	Day 28	37.77 ± 0.18	35.71 ± 1.89c	12.43 ± 1.13c

Reference values according to Garba et al. (2015), Gore et al. (2008).

P_ipTG = piperazine treated group; D_oraTG = doramectin treated group.

^aTreatment day.

^bSignificant when the values at each sampling day (7, 14, 21 or 28) compared with the value day 0 in P_ipTG (p < 0.05).

^cSignificant when the values at each sampling day (7, 14, 21 or 28) compared with the value at day 0 in D_oraTG (p < 0.05).